BioSpace News Archive

Phase 1 data showed rapid, sustained and >95% inhibition of alternative pathway of complement system with 100 mg of oral BCX9930 BID

Enrollment in MOMENTUM Phase 3 migraine trial of AXS-07 in patients with history of inadequate response nearly complete; on track for topline results in 4Q 2019

Follicular lymphoma cohort met the primary endpoint of overall response rate (ORR)

Bio-Techne Corporation, a global leader in the development and manufacturing of Good Manufacturing Practices -grade raw and ancillary reagents, announced a commitment to invest between $40 million and $50 million to expand its GMP-grade protein production capacity.

Nuventra Pharma Sciences is pleased to announce the addition of Iftekhar Mahmood, Ph.D., to its growing team of experienced consultants. Dr. Mahmood has more than 25 years of clinical pharmacology experience at the FDA..

Castle Biosciences, Inc. announced that it will release its financial results for the third quarter ended September 30, 2019, after the close of market on Monday, November 11, 2019.

VIVUS, Inc. (Nasdaq: VVUS) (the “Company”), a biopharmaceutical company, announced today that Eric W. Roberts and Allan L. Shaw have resigned from its Board of Directors and all of its committees in order to increase their focus on other personal business interests.

Biohaven Pharmaceutical Holding Company Ltd. (NYSE: BHVN), a clinical-stage biopharmaceutical company with a portfolio of innovative, late-stage product candidates targeting neurologic and neuropsychiatric diseases, today announced that it has completed enrollment in its pivotal Phase 3 clinical trial assessing the efficacy and safety of troriluzole in generalized anxiety disorder (GAD).

VITAS® Healthcare, the nation’s leading provider of end-of-life care, has named Rory Farrand as director of VITAS® Palliative Care.

Vaxart, Inc. (NASDAQ: VXRT), a clinical-stage biotechnology company developing oral recombinant vaccines that are administered by tablet rather than by injection, today announced that four new members have been appointed to the Board of Directors effective immediately.